A detailed history of Romano Brothers And Company transactions in Zoetis Inc. stock. As of the latest transaction made, Romano Brothers And Company holds 3,391 shares of ZTS stock, worth $614,856. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,391
Previous 3,316 2.26%
Holding current value
$614,856
Previous $574,000 15.33%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$172.58 - $196.48 $12,943 - $14,736
75 Added 2.26%
3,391 $662,000
Q2 2024

Jul 17, 2024

BUY
$145.54 - $178.83 $482,610 - $593,000
3,316 New
3,316 $574,000
Q3 2023

Oct 17, 2023

BUY
$167.14 - $192.77 $3.9 Million - $4.5 Million
23,329 New
23,329 $4.06 Million
Q4 2022

Jan 17, 2023

BUY
$131.14 - $157.47 $77,110 - $92,592
588 New
588 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Romano Brothers And Company Portfolio

Follow Romano Brothers And Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

News

Stay updated on Romano Brothers And Company with notifications on news.